Literature DB >> 20800607

Sub-lethal dosing of azaspiracid-1 in female NMRI mice.

John A B Aasen1, Arild Espenes, Philipp Hess, Tore Aune.   

Abstract

The main aim of this study was to examine absorption and pathological effects of a single sub-lethal dose of the marine biotoxin azaspiracid-1 (AZA1) in mice after oral intubation. When the mice received AZA1 at doses of 100, 200 or 300 μg/kg body weight (b.w.), the toxin was absorbed dose-dependently. Highest concentrations after 24 h were detected in kidneys, spleen and lungs, followed by liver and heart. Only trace amounts were seen in the brain. After seven days, the toxin level had dropped significantly in all organs except for the kidneys. The amount of toxin absorbed was highest in the liver, followed by kidneys, lungs, spleen and heart and the total amount of toxin in the internal organs analysed after 24 h was estimated to be only about 2% of the total amount given for all three dose groups. Pathological changes were only detected in the upper part of the small intestine (duodenum), consisting of mild cellular detachment in the tips of the villi, expansion of the crypts and necrotic changes in lamina propria. In a previous study very long persistence of damage to the gastrointestinal tract by repeated exposures to AZA toxins was reported. In our study, full recovery from the pathological changes was observed seven days after a single exposure to AZA1 at the doses applied.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800607     DOI: 10.1016/j.toxicon.2010.08.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

1.  Subacute Cardiovascular Toxicity of the Marine Phycotoxin Azaspiracid-1 in Rats.

Authors:  Sara F Ferreiro; Natalia Vilariño; Cristina Carrera; M Carmen Louzao; Antonio G Cantalapiedra; Germán Santamarina; J Manuel Cifuentes; Andrés C Vieira; Luis M Botana
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

2.  In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.

Authors:  Sara F Ferreiro; Natalia Vilariño; Cristina Carrera; M Carmen Louzao; Germán Santamarina; Antonio G Cantalapiedra; Laura P Rodríguez; J Manuel Cifuentes; Andrés C Vieira; K C Nicolaou; Michael O Frederick; Luis M Botana
Journal:  Arch Toxicol       Date:  2013-08-11       Impact factor: 5.153

3.  Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels.

Authors:  Michael J Twiner; Gregory J Doucette; Andrew Rasky; Xi-Ping Huang; Bryan L Roth; Michael C Sanguinetti
Journal:  Chem Res Toxicol       Date:  2012-08-10       Impact factor: 3.739

Review 4.  Current Trends and New Challenges in Marine Phycotoxins.

Authors:  Maria Carmen Louzao; Natalia Vilariño; Carmen Vale; Celia Costas; Alejandro Cao; Sandra Raposo-Garcia; Mercedes R Vieytes; Luis M Botana
Journal:  Mar Drugs       Date:  2022-03-08       Impact factor: 5.118

Review 5.  Human Poisoning from Marine Toxins: Unknowns for Optimal Consumer Protection.

Authors:  Natalia Vilariño; M Carmen Louzao; Paula Abal; Eva Cagide; Cristina Carrera; Mercedes R Vieytes; Luis M Botana
Journal:  Toxins (Basel)       Date:  2018-08-09       Impact factor: 4.546

6.  Azaspiracids Increase Mitochondrial Dehydrogenases Activity in Hepatocytes: Involvement of Potassium and Chloride Ions.

Authors:  Marco Pelin; Jane Kilcoyne; Chiara Florio; Philipp Hess; Aurelia Tubaro; Silvio Sosa
Journal:  Mar Drugs       Date:  2019-05-08       Impact factor: 5.118

Review 7.  Risk assessment of shellfish toxins.

Authors:  Rex Munday; John Reeve
Journal:  Toxins (Basel)       Date:  2013-11-11       Impact factor: 4.546

Review 8.  Emerging Marine Biotoxins in European Waters: Potential Risks and Analytical Challenges.

Authors:  Paz Otero; Marisa Silva
Journal:  Mar Drugs       Date:  2022-03-08       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.